Analyses do not support CYP17 genotype-estradiol associations

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1550-

  Vitzthum, Virginia J ^a   Thornburg, Jonathan ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 17; ESTRADIOL; BIOLOGICAL MARKER; STEROID 17ALPHA MONOOXYGENASE;

A1A1 GENE; A1A2 GENE; A2A2 GENE; ADULT; ANALYSIS OF VARIANCE; ANOVULATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE; GENOTYPE; HUMAN; LETTER; MENSTRUAL CYCLE; POLAND; PRIORITY JOURNAL; RURAL POPULATION; SALIVA ANALYSIS; URBAN POPULATION; ALLELE; BIOSYNTHESIS; ENDOCRINE SYSTEM; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; METABOLISM; NOTE; SALIVA;

ADULT; ALLELES; BIOLOGICAL MARKERS; ENDOCRINE SYSTEM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MENSTRUAL CYCLE; SALIVA; STEROID 17-ALPHA-HYDROXYLASE; VARIATION (GENETICS);

EID: 53349098002     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0016     Document Type: Letter

References (3)

1. Jasienska G, Kapiszewska M, Bilison PT, et al. CYP17 genotypes differ in salivary 17-β estradiol levels: a study based on hormonal profiles from entire menstrual cycles. Cancer Epidemiol Biomarkers Prev 2006;15:2131-5.
2. Swain MC, et al. Ovulatory failure in a normal population and in patients with breast cancer. J Obstet Gynaecol Br Commonw 1974;481:640-43.
3. Available from: http://www.statsoft.com/textbook/stathome.html.